AEHR Test Systems buy BiotechBee
Start price
03.09.23
/
70%
€48.70
Target price
30.09.25
€60.00
Performance (%)
-54.17%
End price
02.12.23
€22.32
Summary
This prediction ended on 02.12.23 with a price of €22.32. Massive losses of -54.17% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AEHR Test Systems | 9.614% | 9.614% | 854.962% |
| iShares Core DAX® | 0.271% | 1.796% | 4.850% |
| iShares Nasdaq 100 | 1.884% | 2.153% | 37.074% |
| iShares Nikkei 225® | 3.579% | 5.306% | 58.395% |
| iShares S&P 500 | 0.151% | 1.090% | 25.282% |
According to BiotechBee what are the pros and cons of AEHR Test Systems for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aehr Test Systems diskutieren
Buy mit Kursziel 60,0